ArticleMolecular cancer2014

MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.

Kai-Liang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.